2026-01-28 – Press Releases – www.prnewswire.com
BELTSVILLE, Md., Jan. 29, 2026 /PRNewswire/ — REPROCELL today announced the commercial launch of StemEdit, its clinical gene editing services and new gene-edited iPSC product lines leveraging OpenCRISPR-1, an AI-designed genome editing system licensed from Profluent (Emeryville, CA,…
